Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metformin+Sitagliptin”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00961480
What this trial is testing

Demonstrate the Bioequivalence of Sitagliptin/Metformin Combination Tablets and Co-administration of Sitagliptin and Metformin as Individual Tablets (0431A-095)

Who this might be right for
Type 2 Diabetes
Merck Sharp & Dohme LLC 24
Post-approval studies (Phase 4)Study completedNCT02188186
What this trial is testing

Therapeutic Efficacy of Triple Combination in Drug-naïve Korean Type 2 Diabetic Patients

Who this might be right for
Type 2 Diabetes
Seoul National University Bundang Hospital 200
Large-scale testing (Phase 3)Study completedNCT01590797
What this trial is testing

A Study in China Evaluating the Safety and Efficacy of Adding Sitagliptin to Stable Therapy With Insulin With or Without Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-254)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 467
Post-approval studies (Phase 4)Enrolling By InvitationNCT07452913
What this trial is testing

Metformin, Empagliflozin With Sitagliptin vs Linagliptin in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
Bahria University 110
Post-approval studies (Phase 4)Study completedNCT01859793
What this trial is testing

Effects of Sitagliptin on Endothelial Function in Type 2 Diabetes on Background Metformin Therapy

Who this might be right for
DiabetesAtherosclerosis
Medical College of Wisconsin 38
Not applicableEnded earlyNCT01357148
What this trial is testing

A Post Marketing Safety Study of Sitagliptin Phosphate/Metformin Hydrochloride (JANUMET®) (MK-0431A-235)

Who this might be right for
Diabetes Mellitus, Type 2
Merck Sharp & Dohme LLC 143
Large-scale testing (Phase 3)Study completedNCT02452632
What this trial is testing

Assess the Efficacy and Safety of ASP1941 in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin

Who this might be right for
Type 2 Diabetes Mellitus
Astellas Pharma Korea, Inc. 143
Testing effectiveness (Phase 2)Study completedNCT01336738
What this trial is testing

Study Of Safety And Efficacy Of PF-04991532 In Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes, Type 2
Pfizer 266
Post-approval studies (Phase 4)Study completedNCT03267576
What this trial is testing

An Efficacy Study of Canagliflozin or Sitagliptin to Determine Glucose Variability in Mexican Participants With Type 2 Diabetes Mellitus Inadequately Controlled on Metformin

Who this might be right for
Diabetes Mellitus, Type 2
Janssen Research & Development, LLC 64
Large-scale testing (Phase 3)Study completedNCT00851903
What this trial is testing

Evaluation of Insulin Glargine in Combination With Sitagliptin in Type 2 Diabetes Patients: EASIE Extension Trial

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 112
Early research (Phase 1)Study completedNCT00830076
What this trial is testing

The Effects of Co-Administration of Sitagliptin (MK-0431) and Metformin on Incretin Hormone Concentrations (MK-0431-110)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 18
Testing effectiveness (Phase 2)Study completedNCT00631488
What this trial is testing

Test the Effectiveness and Safety of MK0893 in Combination With Other Drugs Used to Treat Type 2 Diabetes (0893-015)

Who this might be right for
Diabetes Mellitus, Type 2
Merck Sharp & Dohme LLC 146
Early research (Phase 1)Study completedNCT07679711
What this trial is testing

Bioequivalence Study of Sitagliptin/Metformin Extended-Release Tablets in Healthy Subjects

Who this might be right for
Healthy Volunteers
The Affiliated Hospital of Qingdao University 76
Not applicableStudy completedNCT04192292
What this trial is testing

Study of Sulphonylurea Synergy With DPP4 Inhibitors

Who this might be right for
Type 2 Diabetes
University of Dundee 30
Large-scale testing (Phase 3)Study completedNCT02036515
What this trial is testing

Safety and Efficacy of Ertugliflozin in the Treatment of Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin (MK-8835-006; VERTIS SITA2)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 464
Large-scale testing (Phase 3)Study completedNCT00395343
What this trial is testing

Sitagliptin Added-on to Insulin Study (0431-051)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 641
Post-approval studies (Phase 4)Study completedNCT02338921
What this trial is testing

Triple Combination Therapy in Type 2 Diabetic Patients Who Had Inadequate Glycemic Control With Combination Therapy

Who this might be right for
Type 2 Diabetes
Seoul National University Bundang Hospital 78
Large-scale testing (Phase 3)Study completedNCT00754988
What this trial is testing

Taspoglutide Versus Sitagliptin for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin.

Who this might be right for
Diabetes Mellitus Type 2
Hoffmann-La Roche 666
Large-scale testing (Phase 3)Study completedNCT01590771
What this trial is testing

A Study in China Evaluating the Safety and Efficacy of Adding Sitagliptin to Stable Therapy With Sulfonylurea With or Without Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-253)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 498
Post-approval studies (Phase 4)Study completedNCT00833027
What this trial is testing

ALPHA Sitagliptin Add on to Metformin (0431-103)

Who this might be right for
Diabetes Mellitus
Merck Sharp & Dohme LLC 608
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation